Pursuing Slow but Steady Gene Therapy Development
Michael Parini, chief executive officer and director, Freeline Therapeutics, discussed the company’s pipeline and mission.
Global Awareness, Diagnosis a Priority for Rare Diseases: Michael Parini, JD
The chief executive officer and director of Freeline Therapeutics discussed the importance of Rare Disease Day.